Ictero Medical, Inc.
StreetZero Signal 59
About Ictero Medical, Inc.
Ictero Medical, Inc. is a Houston-based medical device startup founded in 2018 that is developing a novel cryoablation system to treat high-risk patients with gallstone disease. The company has raised multiple rounds of funding totaling approximately $7.2M and maintains a partnership with Biotex, Inc. for engineering, product development, and manufacturing. Its technology targets minimally invasive procedures in the gallstone surgical removal space.
LATEST FUNDINGSeries A
$344K
Announced 2026-11-05
TOTAL RAISED$7.2M
IN THE NEWS
- 🔗 Ictero Medical Closes $6M Series A Financing — MedTech Innovator
- 🔗 Ictero Medical - 2026 Company Profile, Team, Funding & Competitors - Tracxn
- 🔗 Ictero Medical - 2026 Company Profile, Team, Funding & Competitors - Tracxn
- 🔗 Ictero Medical, Inc.
- 🔗 Ictero Medical - Products, Competitors, Financials, Employees, Headquarters Locations
EMPLOYEES—
FOUNDED2018
HQHouston, TX, United States
Industry
Other Health Care
Tags
MedTechMedical DeviceCryoablationSeries A
Key highlights
- Closed $6M Series A in 2022 led by MedTex Ventures and S3 Ventures
- Developing cryoablation system for high-risk gallstone patients
- Partnered with Biotex for development and in-house manufacturing
- Total funding of $7.2M with 7 institutional investors
- HQ in Houston with grants from National Science Foundation
Ask StreetZero about Ictero Medical, Inc.
Put our AI to work on this deal.
Similar companies
Other Other Health Care deals, ranked by Signal.
Source document & SEC filing
The source SEC filing and the cached document are available to members only. Sign in to view and download them.
Sign in to view the filing Create free account